Press releases
- BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
- BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
- BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
More ▼
Key statistics
On Friday, Bio-Techne Corp (T1CH34:SAO) closed at 13.48, -5.27% below its 52-week high of 14.23, set on Aug 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.33 |
---|---|
High | 13.49 |
Low | 13.33 |
Bid | 5.00 |
Offer | 14.05 |
Previous close | 13.47 |
Average volume | 1.26k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.0413 BRL |
---|---|
Annual div yield (ADY) | 0.31% |
Div ex-date | May 10 2024 |
Div pay-date | May 31 2024 |
Data delayed at least 15 minutes, as of May 10 2024 20:54 BST.
More ▼